CAPROCK Group Inc. Buys New Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

CAPROCK Group Inc. bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) during the 4th quarter, Holdings Channel.com reports. The institutional investor bought 1,947 shares of the biotechnology company’s stock, valued at approximately $201,000. A number of other hedge funds have also made changes to their positions in the company. Vanguard Group […]

Related Keywords

United States ,America ,Jean Jacques Bienaime ,Johnc Klock ,Brian Mueller ,Stifel Nicolaus ,Charles Schwab Investment Management Inc ,Nasdaq ,Credit Suisse Group ,Caprock Group Inc ,Vanguard Group Inc ,Holdings Channel ,Securities Exchange Commission ,Biomarin Pharmaceutical Inc ,Morgan Stanley ,Millennium Management ,Citigroup ,Group Plc ,Asset Management Americas Inc ,Biomarin Pharmaceutical ,Get Rating ,Management Americas ,General Group Plc ,Charles Schwab Investment Management ,Schwab Investment Management ,Exchange Commission ,Jacques Bienaime ,Marin Pharmaceutical Stock Down ,Marin Pharmaceutical ,Suisse Group ,Visit Holdingschannel ,Biomarin Pharmaceutical Daily ,Nasdaq Bmrn ,Bmrn ,Medical ,09061g10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,